Drug and Device Development from Preclinical to Market

30 years in pharmaceutical and medical device and diagnostics development covering CMC, preclinical, regulatory and clinical drug development from Phase I to Phase IV in US, Canada Europe and Asia. Therapeutic areas include: Cardiovascular CNS Diabetes and Immune Diseases Endocrinology, Dermatology Inflammatory and Infectious Diseases Metabolic Diseases Oncology Urology and Kidney Diseases Women's and Men's Health Care Key competencies:  Strategic Leadership within a matrix environment  Clinical research and drug development  Regulatory  BD, Marketing and Sales support, Financing  Extensive publications and KOL interactions  Recruiting, managing and coaching staff